Schedule 13D ownership disclosure
UROGEN PHARMA LTD
Security class unavailable · CUSIP: M96088105
Event date: 2017-05-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1
- Percent of class
- 10.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-046992
- Form type
- SC 13D
- Filer
- Pontifax Management III G.P. (2011) Ltd.
- CIK
- CIK 1726335
- Filed
- Feb 15, 2018
- Reporting period
- May 04, 2017
- Description
- Schedule 13D beneficial ownership